May 1, 2015
Author(s)
Denis E. Bergeron, Ryan P. Fitzgerald
Ra-223 is an alpha-emitter that is being used as a bone-seeking radiotherapeutic agent. The relatively large uncertainty on its half-life (0.26 %, Bé et al., 2011) is an impediment to precision activity assays. We have performed two series of measurements